INTRANASAL ADMINISTRATION OF ESTRADIOL IN COMBINATION WITH PROGESTERONE TO OOPHORECTOMIZED WOMEN - A PILOT-STUDY

被引:25
作者
HERMENS, WAJJ
BELDER, CWJ
MERKUS, JMWM
HOOYMANS, PM
VERHOEF, J
MERKUS, FWHM
机构
[1] LEIDEN UNIV,CTR BIOPHARMACEUT SCI,POB 9502,2300 RA LEIDEN,NETHERLANDS
[2] MAASLAND HOSP,DEPT CLIN PHARM & TOXICOL,SITTARD,NETHERLANDS
[3] MAASLAND HOSP,DEPT OBSTET & GYNAECOL,GELEEN,NETHERLANDS
[4] MARIA HOSP,DEPT OBSTET & GYNAECOL,TILBURG,NETHERLANDS
来源
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 1992年 / 43卷 / 01期
关键词
ESTRADIOL; INTRANASAL; PROGESTERONE; OOPHORECTOMY;
D O I
10.1016/0028-2243(92)90245-T
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A pilot study was done to investigate the pharmacokinetics and acceptability of an intranasal 17-beta-estradiol/ progesterone formulation. This formulation contained dimethyl-beta-cyclodextrin as a solubilizer and absorption enhancer of the steroid hormones. The study was performed in four oophorectomized and hysterectomized patients. After nasal delivery of 0.34 mg estradiol and 0.85 mg progesterone, concentration-time curves of progesterone, estradiol and its metabolite estrone were established. Rapid absorption of progesterone and estradiol was demonstrated. Progesterone peak-levels (3.9-6.7 nmol/l) exceeded the levels which are found in the-follicular phase of the menstrual cycle, but did not reach the levels of the luteal phase. Comparison with an earlier reported study in which only estradiol was administered shows that the addition of progesterone does not alter the absorption and pharmacokinetics of estradiol. The nasal formulation was well accepted by the four patients and no adverse effects were noted.
引用
收藏
页码:65 / 70
页数:6
相关论文
共 14 条
[1]   NASAL ABSORPTION OF PROGESTERONE IN WOMEN [J].
DALTON, ME ;
BROMHAM, DR ;
AMBROSE, CL ;
OSBORNE, J ;
DALTON, KD .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (01) :84-88
[2]   DISAPPEARANCE RATE OF PROGESTERONE FOLLOWING SIMULTANEOUS REMOVAL OF CORPUS LUTEUM AND FOETO-PLACENTAL UNIT IN WOMEN [J].
FYLLING, P .
ACTA ENDOCRINOLOGICA, 1970, 65 (02) :284-&
[3]   ESTROGENS IN THE PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN [J].
GENANT, HK ;
BAYLINK, DJ ;
GALLAGHER, JC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (06) :1842-1846
[4]   INTRANASAL ESTRADIOL ADMINISTRATION TO OOPHORECTOMIZED WOMEN [J].
HERMENS, WAJJ ;
BELDER, CWJ ;
MERKUS, JMWM ;
HOOYMANS, PM ;
VERHOEF, J ;
MERKUS, FWHM .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1991, 40 (01) :35-41
[5]   PHARMACOLOGY AND PHARMACOKINETICS OF ESTROGENS [J].
LIEVERTZ, RW .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 156 (05) :1289-1293
[6]  
LUCIANO AA, 1988, OBSTET GYNECOL, V71, P39
[7]  
MAGOS AL, 1985, OBSTET GYNECOL, V65, P496
[8]   SERUM LEVELS OF PROGESTERONE AND SOME OF ITS METABOLITES INCLUDING DEOXYCORTICOSTERONE AFTER ORAL AND PARENTERAL ADMINISTRATION [J].
OTTOSON, UB ;
CARLSTROM, K ;
DAMBER, JE ;
VONSCHOULTZ, B .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1984, 91 (11) :1111-1119
[9]   NASAL ABSORPTION OF 17-BETA-ESTRADIOL AND PROGESTERONE FROM A DIMETHYL-CYCLODEXTRIN INCLUSION FORMULATION IN RATS [J].
SCHIPPER, NGM ;
HERMENS, WAJJ ;
ROMEYN, SG ;
VERHOEF, J ;
MERKUS, FWHM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 64 (01) :61-66
[10]   ESTROGEN THERAPY DURING MENOPAUSE - PRACTICAL TREATMENT RECOMMENDATIONS [J].
SITRUKWARE, R .
DRUGS, 1990, 39 (02) :203-217